What is the role of GammaTile in the management of primary brain tumors and brain metastases?
Is there sufficient data to justify the routine use of GammaTile in the treatment of primary CNS malignancy or brain metastases?
Answer from: Radiation Oncologist at Academic Institution
GammaTiles are an intracranial brachytherapy product marketed by GT Medical Technologies consisting of a Cs-131 source imbedded within a collagen matrix. Proponents of the technology argue that advantages of GammaTiles over external beam radiotherapy techniques include the ability to “start&rd...
Comments
Radiation Oncologist at Phoenix CyberKnife and Radiation Oncology Center Dr. @Wilke's summary is concise. I would add that ...
While surgically targeted radiotherapy (STaRT) implants may have a role in the delivery of adjuvant radiation following surgical resection, no specific delivery modality should be considered "routine". Post-operative SRS, along with pre-operative SRS, STaRT, and low-energy X-ray intraoperative radio...
Answer from: Radiation Oncologist at Community Practice
In the setting of de-novo brain metastases, assuming the patient will go on to full-dose chemotherapy, possibly with immunotherapy (i.e. carbo/pem/pem if lung cancer). Given that the half-life of Cs131 is 9.2 days, how long would one wait after implant before administering full-dose chemotherapy?&nb...
Dr. @Wilke's summary is concise. I would add that ...